FindTrial
Sign In

Comparison of two minimally invasive methods of destroying uterine lining in the treatment of heavy menstrual bleeding.

Efficacy of Bipolar Rollerball ablation and Bipolar transcervical resection of the endometrium in the treatment of heavy menstrual bleeding- A Randomized clinical trial. - TCRE verses Rollerball

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007503
Enrollment
80
Registered
2016-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Heavy menstrual bleeding refractory to medical management

Interventions

Intervention1: Roller ball: Roller ball ablation of endometrium using bipolar resectoscope. Control Intervention1: TCRE: Transcervical resection of endometrium done using bipolar resectoscope with ope

Sponsors

Jawaharlal Institute of Postgraduate Medical Education And Research JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Heavy Menstrual Bleeding (Pictorial blood loss assessment chart- PBAC Score >100 2.women who have completed family. 3. Premenopausal 4. Refractory to at least 3 months medical management. 5. Dysfunctional Uterine bleeding

Exclusion criteria

Exclusion criteria: 1.Premenstrual syndrome 2. Chronic pelvic pain 3. Patients not willing for follow up in JIPMER 4.Acute PID 5. Pregnancy

Design outcomes

Primary

MeasureTime frame
To compare the Intraoperative parameters and efficacy of TCRE and Rollerball ablation in reducing heavy menstrual bleeding in premenopausal women.Timepoint: 3, 6 and 12 months after procedure.—

Secondary

MeasureTime frame
To compare the incidence of post ablation pelvic pain in patients undergoing TCRE and Rollerball ablationTimepoint: 3,6 and 12 months after procedure—

Countries

India

Contacts

Public ContactDr Murali Subbaiah

JIPMER, Pondicherry.

muralidraiims@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026